一种CXCR4部分激动剂通过向多态核核髓衍生的抑制细胞和癌症驱动的颗粒形成来改善免疫疗法

概括

用TFF2-MSA来向多态核核髓衍生的抑制细胞 (PMN-MDSCs) 增强了免疫疗法. 这种方法通过减少免疫抑制的PMN-MDSCs和增强抗瘤T细胞反应来恢复胃癌中的抗PD-1敏感性.

相关概念视频

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K